Follicular Lymphoma
A Phase III multi-centre randomised controlled trial of low dose radiotherapy for follicular lymphoma.
Short CHemoRadioImmunotherapy in Follicular Lymphoma Trial of 90Y Ibritumomab tiuxetan (ZevalinTM) as therapy for first and second relapse in Follicular Lymphoma - a Prospective Phase II study